• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Edwards CEO Mussallem announces stock plans | Personnel Moves

Edwards CEO Mussallem announces stock plans | Personnel Moves

May 7, 2012 By MassDevice staff

fired/hired

 Edwards’ CEO Mussallem exercises stock options
Edwards Lifesciences (NYSE:EW) chairman & CEO Michael Mussallem will this month begin exercising stock options that were nearing expiration through a pre-arranged stock trading plan under SEC rule 10b5-1.

The plan allows Mussallem to exercise and sell up to 35,000 shares per month with the intent of spreading sales smoothly over an extended period of time. Under Edwards policy, Mussallem must hold EW shares worth at least 6 times his base salary and at the conclusion of his planned sell-off he will still hold shares "well in excess" of that guideline, according to a press release.

EW shares were up 0.6% to $85.49 as of about 4:15 p.m. today. Read more

 

 SRS Medical promotes Lee Brody to the corner office
Billerica, Mass.-based SRS Medical named Lee Brody, former company COO, to the corner office. Brody plans to focus on growing the company’s non-invasive CT3000 pressure-flow system, according to a statement. Read more

 Advanced Cardiac Therapeutics shuffles the deck, builds its hand to support commercialization
Advanced Cardiac Therapeutics announced the appointment of Bill Olson as president & CEO as the company aims to build support behind commercialization and clinical efforts for its Tempasure cardiac ablation catheter.

The company also added ORSCO Life Sciences founder Oern Stuge to its board of directors and named Miriam Taimisto its VP of research & development. Read more

 CardioKinetix names Maria Sainz president & CEO
Menlo Park, Calif.-based heart failure treatment maker CardioKinetix named Maria Sainz its new president & CEO. With more than 20 years in medical devices, Sainz was most recently general manager for Stryker‘s (NYSE:SYK) neurovascular division. Read more

 Zeltiq interim president & CEO Mark Foley to receive $50k per month
Zeltiq (NSDQ:ZLTQ) named Mark Foley interim president & CEO following the resignation of Gordie Nye, who stepped down for personal reasons mid-April. Foley will receive $50,000 monthly during his stint as interim company head in addition to stock options, according to SEC filings.  Read more

 Lantheus Medical hires Alexander Kuta as VP of global regulatory affairs and Nigel Williams as VP of quality

 C.R. Bard appoints Christopher Holland as chief financial officer

 Toshiba America Medical Systems names Calum Cunningham VP of business operations

Filed Under: News Well, Wall Street Beat Tagged With: CardioKinetix Inc., Edwards Lifesciences, Epix Therapeutics (formerly Advanced Cardiac Therapeutics), Personnel Moves, SRS Medical, Zeltiq

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy